As extra sufferers with most cancers have their tumors genomically profiled, and extra therapies concentrating on genomic alterations enter medical trials, the duty of connecting sufferers to trials for which they’re eligible will be particularly difficult. A pc platform makes the matching course of each simpler and sooner, its designers report in a brand new examine.